Dergiler / Medicine Science / 2022 / Cilt: 11 - Sayı: 1

Flexible approaches are required for successful production of recombinant proteins in plants

Sayfa
447–451
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this mini-review, we discuss the approaches that are needed for the production of functional recombinant proteins such as vaccines, antibodies, enzymes for medical, agricultural, and industrial applications.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Production of recombinant proteins has increased significantly due to the ever-increasing demand in research laboratories, medical fields, and agriculture.
📊
Temel Bulgular & Veri:Despite a variety of recombinant protein expression systems and gene engineering procedures exist owever, there is a limitation in achieving sufficient quantities of active, properly folded recombinant proteins.
💡
Sonuç & Katkı:In this mini-review, we discuss the approaches that are needed for the production of functional recombinant proteins such as vaccines, antibodies, enzymes for medical, agricultural, and industrial applications.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Production of recombinant proteins has increased significantly due to the ever-increasing demand in research laboratories, medical fields, and agriculture. Despite a variety of recombinant protein expression systems and gene engineering procedures exist owever, there is a limitation in achieving sufficient quantities of active, properly folded recombinant proteins. The selection of an appropriate expression system for the production of recombinant proteins should generally be chosen based on the biochemical and biological properties of the desired proteins to be produced. Plant expression platforms offer commercially inexpensive, safe, and fast scale-up properties for the production of recombinant proteins compared to traditional mammalian cell expression systems. However, the absence of some mammalian posttranslational modifications (PTMs) and aberrant N-glycosylation limit the use of these production systems. Therefore, molecular engineering of plant secretory pathways has provided an opportunity to develop next-generation pharmaceuticals with targeted biological functions. In this mini-review, we discuss the approaches that are needed for the production of functional recombinant proteins such as vaccines, antibodies, enzymes for medical, agricultural, and industrial applications.

🔖

Bu Makaleye Atıf Yap

MAMEDOV, T., GÜN, N. (2022). Flexible approaches are required for successful production of recombinant proteins in plants. Medicine Science, Cilt: 11 - Sayı: 1, 447–451. https://ajindex.com/articles/579613

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Nandi S, Kwong AT, Holtz BR, et al. Techno-economic analysis of a transient plant-based platform for monoclonal antibody production. mAbs. 2016;8:1456-66
  2. Gomord V, Faye L. Posttranslational modification of therapeutic proteins in plants. Curr Opin Plant Biol. 2004;7:171-81
  3. Chichester JA, Manceva SD, Rhee A, et al. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores. Hum Vaccin Immunother. 2013;9:544–52
  4. Mamedov T, Ghosh A, Jones RM, et al. Production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expressing bacterial PNGase F. Plant Biotechnol J. 2012;10:773-82
  5. Mamedov T, Yusibov V. In vivo deglycosylation of recombinant proteins in plants by co-expression with bacterial PNGase F. Bioengineered. 2013;4:338-42
  6. Mamedov T, Chichester JA, Jones RM, et al. Production of functionally active and immunogenic non-glycosylated protective antigen from bacillus anthracis in nicotiana benthamiana by co-expression with peptide-nglycosidase f (PNGase F) of flavobacterium meningosepticum. PLoS One. 2016;11:e0153956
  7. Fischer R, Buyel JF. Molecular farming - The slope of enlightenment. Biotechnol Adv. 2020;40:107519
  8. Castilho A, Strasser R, Stadlmann J, et al. In planta protein sialylation through overexpression of the respective mammalian pathway. J Chem Biol. 2010;285:15923-930
  9. Grosse-Holz F, Madeira L, Zahid MA, et al. Three unrelated protease inhibitors enhance accumulation of pharmaceutical recombinant proteins in Nicotiana benthamiana. Plant Biotechnol J. 2018;16:1797–810
  10. Gomord V, Sourrouille C, Fitchette AC, et al. Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. Plant Biotechnol J. 2004;2:83-100
  11. Gomord V, Denmat LA, Fitchette-Lainé AC, et al. The C-terminal HDEL sequence is sufficient for retention of secretory proteins in the endoplasmic reticulum (ER) but promotes vacuolar targeting of proteins that escape the ER. Plant J. 1997;11:313-25
  12. Saint-Jore-Dupas C, Faye L, Gomord V. From planta to pharma with glycosylation in the toolbox. Trends Biotechnol. 2007;25:317-23
  13. Strasser R, Castilho A, Stadlmann J, et al. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4- galactosylated N-glycan profile. J Biol Chem. 2009;284:20479–485
  14. Lerouge P, Cabanes-Macheteau M, Rayon C, et al. N-glycoprotein biosynthesis